Paper · 53266
Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex.
Rehn TG and 3 others. J Exp Med, 1976. Cited by 41 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex. Papers, record 53266. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/53266
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Cellular | Major topic |
| Lymphocytes | Major topic |
| Neoplasms, Experimental | Major topic |
| Nitrohydroxyiodophenylacetate | Major topic |
| Nitrophenols | Major topic |
| Animals | |
| Cell Line | |
| Epitopes | |
| Genes | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred DBA | |
| Species Specificity | |
| Spleen |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,079,848 | On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets. | J Exp Med | 1975 | https://conductscience.org/library/papers/1079848 | PubMed |
| 2 | 1,079,922 | Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus. | Nature | 1975 | https://conductscience.org/library/papers/1079922 | PubMed |
| 3 | 1,086,219 | Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex. | Eur J Immunol | 1975 | https://conductscience.org/library/papers/1086219 | PubMed |
| 4 | 123,002 | H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. | J Exp Med | 1975 | https://conductscience.org/library/papers/123002 | PubMed |
| 5 | 4,122,709 | Cell interactions between histoincompatible T and B lymphocytes. II. Failure of physiologic cooperative interactions between T and B lymphocytes from allogeneic donor strains in humoral response to hapten-protein conjugates. | J Exp Med | 1973 | https://conductscience.org/library/papers/4122709 | PubMed |
| 6 | 4,133,807 | Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. | Nature | 1974 | https://conductscience.org/library/papers/4133807 | PubMed |
| 7 | 4,211,857 | Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics. | Eur J Immunol | 1974 | https://conductscience.org/library/papers/4211857 | PubMed |
| 8 | 4,547,153 | Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes. | Eur J Immunol | 1974 | https://conductscience.org/library/papers/4547153 | PubMed |
| 9 | 4,547,543 | Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. | Nature | 1974 | https://conductscience.org/library/papers/4547543 | PubMed |
| 10 | 4,591,829 | Coupling of large haptens to proteins and cell surfaces: preparation of stable, optimally sensitized erythrocytes for hapten-specific, hemolytic plaque assays. | Immunochemistry | 1973 | https://conductscience.org/library/papers/4591829 | PubMed |
1 to 10 of 15
See all 15 referencesCited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,600,441 | Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid. | Immunology | 1983 | https://conductscience.org/library/papers/6600441 | PubMed |
| 2,933,141 | The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/2933141 | PubMed |
| 1,087,329 | Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region. | J Exp Med | 1976 | https://conductscience.org/library/papers/1087329 | PubMed |
| 300,775 | Secondary in vitro responses of T lymphocytes to non-H-2 alloantigens self-H-2-restricted responses induced in heterologous serum are not dependent on primary-stimulating non-H-2 alloantigens. | J Exp Med | 1977 | https://conductscience.org/library/papers/300775 | PubMed |
| 199,844 | Non-infectious virus induces cytotoxic T lymphocytes and binds to target cells to permit their lysis. | Nature | 1977 | https://conductscience.org/library/papers/199844 | PubMed |
| 75,547 | Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/75547 | PubMed |
| 75,237 | H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins. | J Exp Med | 1978 | https://conductscience.org/library/papers/75237 | PubMed |
| 70,501 | Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran. | J Exp Med | 1977 | https://conductscience.org/library/papers/70501 | PubMed |
| 62,013 | Cell-mediated lympholysis to H-2-matched target cells modified with a series of nitrophenyl compounds. | J Exp Med | 1976 | https://conductscience.org/library/papers/62013 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/53266
GET https://conductscience.org/api/papers/v1/53266/authors